Population Sciences Program

$82,717P30FY2016CANIH

Roswell Park Cancer Institute Corp, Buffalo NY

Investigators

Linked publications & trials

Paper 39671382 Paper 39663510 Paper 39638782 Paper 39565188 Paper 39505323 Paper 39467133 Paper 39457723 Paper 39436987 Paper 39427167 Paper 39409866 Paper 39392882 Paper 39383197 Paper 39372930 Paper 39372426 Paper 39364604 Paper 39363904 Paper 39315270 Paper 39301939 Paper 39282391 Paper 39272962 Paper 39244627 Paper 39229130 Paper 39227674 Paper 39189591 Paper 39149372 Paper 39143423 Paper 39143271 Paper 39111128 Paper 39092502 Paper 39072034 Paper 39057951 Paper 39054343 Paper 39039296 Paper 39024561 Paper 39015090 Paper 38968073 Paper 38949179 Paper 38947068 Paper 38946549 Paper 38946542 Paper 38918593 Paper 38915482 Paper 38902348 Paper 38896060 Paper 38886818 Paper 38881188 Paper 38878775 Paper 38871977 Paper 38848543 Paper 38845078 Paper 38842305 Paper 38839633 Paper 38802116 Paper 38801976 Paper 38701390 Paper 38701089 Paper 38690835 Paper 38672591 Paper 38646087 Paper 38616706 Paper 38614979 Paper 38611012 Paper 38610936 Paper 38585981 Paper 38581346 Paper 38566104 Paper 38562904 Paper 38555305 Paper 38553892 Paper 38541046 Paper 38540156 Paper 38535913 Paper 38530242 Paper 38523867 Paper 38521965 Paper 38513170 Paper 38496424 Paper 38480032 Paper 38423748 Paper 38408431 Paper 38400098 Paper 38398074 Paper 38397617 Paper 38396800 Paper 38389933 Paper 38378740 Paper 38376917 Paper 38352414 Paper 38323295 Paper 38323277 Paper 38314444 Paper 38294344 Paper 38274724 Paper 38270582 Paper 38260290 Paper 38245540 Paper 38242909 Paper 38233562 Paper 38232613 Paper 38201574

Abstract

The Population Science (PS) Program's overall goal is to reduce and prevent morbidity and mortality associated with cancer and its treatment, particularly through identification of genetic and modifiable factors that may influence adverse outcomes. To address this goal, our research is focused around four themes, each of which includes research along the cancer continuum ranging from cancer etiology to cancer treatment outcomes: Nutrition and Chemoprevention; Molecular Epidemiology of Cancer Risk and Prognosis; Cancer Health Disparities; and Tobacco Epidemiology and Translation into Policy. Molecular Epidemiology and Cancer Health Disparities particularly are critical and broadly considered concepts in all themes. The Program members seek to address cancer-related problems that are important to the community that we serve, with outreach, education and interventions to reduce cancer risk and morbidity within our catchment area. The PS program is co-led by Drs. Christine Ambrosone and James Marshall, who together facilitate research in discovery, to identify genetic and environmental causes of cancer and its outcomes; prevention interventions, particularly among those at greatest risk; translation and dissemination to the community; and to ultimately impact policy, particularly related to tobacco. PS seeks to translate basic and clinical science findings to human populations, integrating basic science with cancer epidemiology. PS members include scientists with expertise in each of these areas. Program themes have matured and expanded over the last funding cycle, enhanced by receipt of a number of ROl grants supporting molecular epidemiology of cancer risk and prognosis, disparities research, including POl and U54 grants, ROl and U01-funded dietary interventions, and continued NCI and FDA support for tobacco research. The PS Program is comprised of 22 members from 7 RPCI departments (Cancer Prevention and Control, Health Behavior, Medicine, Surgical !Oncology, Urology, and Dentistry), whose total peer-reviewed funding is $17.4M (NCI funding $12M) and total funding is $22.6M. This compares favorably to $11M peer reviewed/$17M total funding at the time of the last renewal. Of the 4g9 publications generated over the last funding cycle, 28% are intra-programmatic and 15% are inter-programmatic; 40 publications were in journals with an Impact Factor > 10.

View original record on NIH RePORTER →